Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

436 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Completed

A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis

NCT01362231

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • Arizona Pulmonary Specialists Scottsdale, Arizona, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Loess Hills Clinical Research Center Council Bluffs, Iowa, United States
View Trial Details
Completed

Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis

NCT00517933

Conditions
Cardiovascular Diseases, Fibrosis, Hypertension, +9 more
Locations
  • University of Alabama - Birmingham Birmingham, Alabama, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • University of California - San Francisco San Francisco, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
View all 13 locations
View Trial Details
Completed

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

NCT00650091

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • University of Alabama - Birmingham Birmingham, Alabama, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • University of California - San Francisco San Francisco, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
View all 26 locations
View Trial Details
Completed

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF

NCT01136174

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • 1199.31.002 Boehringer Ingelheim Investigational Site Bunkyo-ku,Tokyo, Japan
  • 1199.31.004 Boehringer Ingelheim Investigational Site Hamamatsu, Shizuoka, Japan
  • 1199.31.008 Boehringer Ingelheim Investigational Site Himeji, Hyogo, Japan
  • 1199.31.006 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan
View Trial Details

Related conditions